EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Progress on the Regulatory Role of Treg Cells in Inflammatory Eye Diseases

Zitong Pan iD, Yi Wang, Jieya Zhang, Xiaoran Bian iD, Huaxue Zhang iD, Jiahao Pan iD, Xinyu Wang iD, Dadong Guo

Current Issues in Molecular Biology · 25.05.2026 · 48 (6) · 555

DOI: 10.3390/cimb48060555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 25.05.2026. Verfasst von Zitong Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Ophthalmology and Optometry, Shandong University of Traditional Chinese Medicine, Jinan 250002, China. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation for Young Scholars, Shandong University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs, CD4+ CD25+ Foxp3+) play a crucial role as a core cell subset in maintaining immune homeostasis in the ocular immune-privileged microenvironment. This review systematically summarizes the stage-specific regulatory mechanisms of Treg cells in common inflammatory diseases such as keratitis, uveitis, and dry eye syndrome, including intercellular interactions, signal pathway mediation, and cytokine network regulation, as well as key experimental evidence (animal/cell models and clinical sample data) and research progress in targeted therapy. Studies have shown that Treg cells maintain ocular immune balance by secreting anti-inflammatory cytokines (such as IL-10 and TGF-β), regulating signaling pathways (STAT, PI3K/AKT, SIRT1, etc.), and interacting with immune cells (macrophages, dendritic cells). Their functions are regulated by multiple factors such as cytokine networks, epigenetic modifications, and delivery vectors. Targeted interventions based on Treg cells (cell therapy, drug intervention, and signaling pathway regulation) and combined treatment strategies have shown good anti-inflammatory potential. This article, in light of current research limitations (such as insufficient analysis of cell heterogeneity and the disconnect between basic and clinical research), proposes future research directions, providing a theoretical basis for the understanding of the pathogenesis of inflammatory eye diseases and the development of new immunomodulatory therapies, and establishing a complete research framework of “mechanism–evidence–treatment”.

Schlagwörter

Stichwörter der Autor:innen

immune regulationinflammatory eye diseasesregulatory T cellssignal pathwaystargeted intervention

Autor:innen und Institutionen

  • College of Ophthalmology and Optometry, Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • Institute for Chinese Medicine and Brain Science, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Jinan 250355, China.
  • Shandong Key Laboratory of Innovation and Application Research in Basic Theory of Traditional Chinese Medicine, Jinan 250355, China.
  • Shandong Provincial Engineering Research Center for the Prevention and Treatment of Major Brain Diseases with Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

ORCID-Profile: Zitong Pan, Xiaoran Bian, Huaxue Zhang, Jiahao Pan, Xinyu Wang

Förderung

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation for Young Scholars
  • Shandong University of Traditional Chinese Medicine
  • Key project of science and technology of Traditional Chinese medicine in Shandong Province
  • The Second Batch of Scientific Research Funds of Shandong University of Traditional Chinese Medicine

Zitieren

APA

Pan, Z., Wang, Y., Zhang, J., Bian, X., Zhang, H., Pan, J., Wang, X., & Guo, D. (2026). Research Progress on the Regulatory Role of Treg Cells in Inflammatory Eye Diseases. Current Issues in Molecular Biology, 48(6), 555. https://doi.org/10.3390/cimb48060555

Vancouver

Pan Z, Wang Y, Zhang J, Bian X, Zhang H, Pan J, et al. Research Progress on the Regulatory Role of Treg Cells in Inflammatory Eye Diseases. Current Issues in Molecular Biology. 2026;48(6):555. doi:10.3390/cimb48060555

BibTeX
@article{Pan2026,
  author = {Pan, Zitong and Wang, Yi and Zhang, Jieya and Bian, Xiaoran and Zhang, Huaxue and Pan, Jiahao and Wang, Xinyu and Guo, Dadong},
  title = {Research Progress on the Regulatory Role of Treg Cells in Inflammatory Eye Diseases},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {6},
  pages = {555},
  doi = {10.3390/cimb48060555}
}
Kostenlos starten →